secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
CIK:        0001979414
Form:       8-K
Filed at:   2025-06-06T23:59:59+00:00
Accession:  0001829126-25-004324
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeOnc Technologies appoints Josh Neman as Chief Clinical Officer
----------------------------------------------------------------

- Josh Neman appointed Chief Clinical Officer effective June 5, 2025; base salary $165,000/year.
- Granted 200,000 RSUs: 1/3 vest Dec 30, 2025; 1/3 in 29 monthly installments; 1/3 performance-based.
- Neman will continue his role as Associate Professor at USC Keck School of Medicine.
- Neman also serves as CEO of Synaptical Inc. and CNSMENDER Consulting.
- Employment term is 12 months with automatic annual renewal; at-will employment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1979414/000182912625004324/0001829126-25-004324-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1979414/000182912625004324/neonctechnologies_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-25-004324

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer